Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complement Mediated Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 0 results

Not applicableAvailableNCT04288713
What this trial is testing

Eculizumab (Soliris) in Covid-19 Infected Patients

Who this might be right for
Coronavirus
Hudson Medical
Testing effectiveness (Phase 2)Looking for participantsNCT06989359
What this trial is testing

Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

Who this might be right for
IgANC3GComplement-mediated Kidney Disease+2 more
ADARx Pharmaceuticals, Inc. 45
Testing effectiveness (Phase 2)Study completedNCT03124368
What this trial is testing

A Proof-of-Mechanism Study to Determine the Effect of Danicopan on C3 Levels in Participants With C3G or IC-MPGN

Who this might be right for
C3 GlomerulonephritisDense Deposit DiseaseC3 Glomerulopathy+2 more
Alexion Pharmaceuticals, Inc. 6
Testing effectiveness (Phase 2)Looking for participantsNCT06853223
What this trial is testing

This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction

Who this might be right for
Primary Graft DysfunctionLung TransplantationAcute Lung Injury(ALI)+1 more
University of California, San Francisco 120
Not applicableStudy completedNCT01945307
What this trial is testing

Complement 2: Blood Donations to Develop Vaccines Against Infectious Diseases

Who this might be right for
Complement Mediated Bacterial Killing in Healthy Adults
University of Oxford 101
Early research (Phase 1)Study completedNCT02983006
What this trial is testing

Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Melanoma
NYU Langone Health 12
Early research (Phase 1)UnknownNCT06560593
What this trial is testing

Clinical Trial of NTQ5082 in Healthy Volunteers

Who this might be right for
Complement-mediated Hemolytic Diseases
Nanjing Chia-tai Tianqing Pharmaceutical 82
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05517980
What this trial is testing

Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis

Who this might be right for
Glomerulonephritis
Kira Pharmacenticals (US), LLC. 52
Not applicableActive Not RecruitingNCT05985122
What this trial is testing

New Analytic Tools for aHUS and C3G Diagnosis

Who this might be right for
Hemolytic-Uremic SyndromeMembranoproliferative GlomerulonephritisHealthy
Mario Negri Institute for Pharmacological Research 180
Early research (Phase 1)Study completedNCT05937581
What this trial is testing

First-In-Human Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Escalating Single And Multiple Doses Of CSL040 In Healthy Subjects

Who this might be right for
Complement-mediated Disorders
CSL Behring 62
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07363265
What this trial is testing

Efficacy and Safety of LP-005 Injection in Patients With Complement-Mediated Kidney Disease

Who this might be right for
Complement-mediated Renal Diseases
Longbio Pharma 46
Not applicableEnded earlyNCT05095623
What this trial is testing

A Natural History Study to Assess the Clinical Outcomes of Patients With Complement Factor I Deficiency-Mediated Disease

Who this might be right for
Recurrent Bacterial Infection, Autoimmune Disorder
Catalyst Biosciences 3
Early research (Phase 1)Looking for participantsNCT07462780
What this trial is testing

A Phase I Clinical Trial to Evaluate CMS-D017 Following Single and Multiple Doses in Healthy Participants

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria, PNHComplement-mediated Kidney Disease
Shenzhen Kangzhe Biotechnology Co., Ltd. 88
Early research (Phase 1)Enrolling By InvitationNCT06723106
What this trial is testing

Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)

Who this might be right for
Antiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)+3 more
Chugai Pharmaceutical 144
Not applicableNot Yet RecruitingNCT07331259
What this trial is testing

CHART-C3G/CLNP023B12011

Who this might be right for
C3 GlomerulopathyComplement-mediated Kidney DiseaseProteinuria
Novartis Pharmaceuticals 83
Post-approval studies (Phase 4)Study completedNCT07290855
What this trial is testing

Evaluate the Safety and Efficacy of Icatibant in Patients With Bradykinin Induced Angioedema

Who this might be right for
Bradykinin-mediated AngioedemaHereditary Angioedema (HAE)
Nang Kuang Pharmaceutical Co., Ltd. 5